ATS 2024 Final Program

Click on the session title to view the speakers

28

SUNDAY • MAYs 19

10:15 Co-transplantation of Alveolar Macrophages Improves the Efficacy of Endothelial Progenitor Cell Therapy in Mouse Model of Bronchopulmonary Dysplasia 10:27 Lipofibroblast-Conditioned Media Suppresses Fibrogenesis in Pulmonary Myofibroblasts 10:39 Buloxibutid, A Novel Angiotensin II Type 2 Receptor Agonist, Stabilized and Improved Lung Function in Individuals With Idiopathic Pulmonary Fibrosis in the 36-week Phase 2 AIR Trial 10:51 ENV-101, A Novel Hedgehog Inhibitor, Increases Lung Function, and Reduces Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis: Results From a Randomized, Double-blind, Placebo-controlled Phase 2 Trial 11:03 Clinical Stage Drug Candidate LAU-7b Shows Potent Antifibrotic Properties in Several Preclinical Models of Pulmonary Fibrosis A19 THE FRONTLINE SLEEP APNEA: INNOVATIONS IN OSA 9:15 a.m. - 11:15 a.m. Oral Presentations: 9:15 Individualized Treatment Effects of CPAP in Obstructive Sleep Apnea: A Post-hoc Machine Learning Analysis in Save 9:27 Stepwise and Targeted Therapy to Treat Sleep Apnea: A Novel, Physiology-informed, Personalised Approach Using Oral Appliance Therapy Plus Combination Therapy in Incomplete Responders 9:39 An Optogenetics-based Therapy for Obstructive Sleep Apnea 9:51 Combination Drug Therapy With Acetazolamide, Eszopiclone +/- Venlaflaxine for Obstructive Sleep Apnea: A Randomized, Controlled Clinical Trial 10:03 Treatment of Sleep-disordered Breathing With Adaptive Servo-ventilation (READ-ASV) in Opioid Users: A European Registry San Diego Convention Center Room 32A-B (Upper Level) CLINICAL MINI SYMPOSIUM

10:15 Assessment of Sleep Apnea-specific Hypoxic Burden (SASHB) With Novel Oral Appliance Optima and Oral Positive Expiratory Pressure Accessory ExVent 10:27 A Novel Sensor to Track Transient Blood Pressure Changes During Sleep 10:39 Site of Collapse Probability Determined Using Airflow Shapes Is Associated With REM Sleep 10:51 Percutaneous Approaches to Hypoglossal Nerve Stimulation: A Pilot Study During Drug-Induced Sleep Endoscopy 11:03 The Effect of Ansa Cervicalis Stimulation on Upper Airway Patency: A Structure-based Analysis A21 HEALTH SERVICES RESEARCH: HIGHLIGHTS OF EPIDEMIOLOGY, POPULATION HEALTH, COST, AND OUTCOMES 9:15 a.m. - 11:15 a.m. San Diego Convention Center Room 25A-C (Upper Level) Poster Viewing 9:15-10:00 Discussion 10:00-11:15 401 Trends in All-cause Mortality Among U.S. Veterans With Sarcoidosis From 2004-2022 402 Care Patterns of Patients With Connective Tissue Disease-related Interstitial Lung Disease 403 Evaluating the Impact of Supplemental Oxygen Therapy on Clinical and Economic Outcomes in Patients With Fibrosing Interstitial Lung Disease 404 Lung Cancer Mortality Trends and Disparities: A Cross-sectional Analysis 1999-2020 405 Characteristics, Outcomes, and Healthcare Resource Utilization of Patients Hospitalized With Vaping Related Lung Injury in the US, 2020 406 Portable Oxygen Concentrators and Level of Mobility in Long-term Oxygen Therapy Patients in France. A Nationwide Health Claims Database (SNDS) Study BEHAVIORAL • CLINICAL POSTER DISCUSSION SESSION

ATS 2024 Conference Program • San Diego, CA